125 related articles for article (PubMed ID: 3095539)
1. Actions of nizatidine on the rat uterus, dog stomach and experimentally induced gastric lesions.
Lin TM; Evans DC; Warrick MW; Ruffolo RR
J Pharmacol Exp Ther; 1986 Nov; 239(2):400-5. PubMed ID: 3095539
[TBL] [Abstract][Full Text] [Related]
2. Actions of nizatidine, a selective histamine H2-receptor antagonist, on gastric acid secretion in dogs, rats and frogs.
Lin TM; Evans DC; Warrick MW; Pioch RP
J Pharmacol Exp Ther; 1986 Nov; 239(2):406-10. PubMed ID: 2877081
[TBL] [Abstract][Full Text] [Related]
3. Gastroprokinetic activity of nizatidine, a new H2-receptor antagonist, and its possible mechanism of action in dogs and rats.
Ueki S; Seiki M; Yoneta T; Aita H; Chaki K; Hori Y; Morita H; Tagashira E; Itoh Z
J Pharmacol Exp Ther; 1993 Jan; 264(1):152-7. PubMed ID: 8093722
[TBL] [Abstract][Full Text] [Related]
4. Gastroprokinetic activity of nizatidine during the digestive state in the dog and rat.
Ueki S; Matsunaga Y; Yoneta T; Tamaki H; Itoh Z
Arzneimittelforschung; 1999 Jul; 49(7):618-25. PubMed ID: 10442211
[TBL] [Abstract][Full Text] [Related]
5. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
Cavanagh RL; Usakewicz JJ; Buyniski JP
J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
[TBL] [Abstract][Full Text] [Related]
6. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
Ishikawa H; Ito H; Higaki M; Higaki M; Matsumoto Y; Kamimura T; Katsura Y; Tomishi T; Inoue Y; Takasugi H; Tomoi M; Krakowka S; Yoshida K
Eur J Pharmacol; 1999 Aug; 378(3):299-310. PubMed ID: 10493106
[TBL] [Abstract][Full Text] [Related]
7. Histamine H2-receptor antagonistic action of N-(3-[3-(1-piperidinylmethyl)phenoxy]propyl)acetoxyacetamide hydrochloride (TZU-0460).
Tarutani M; Sakuma H; Shiratsuchi K; Mieda M
Arzneimittelforschung; 1985; 35(4):703-6. PubMed ID: 2861823
[TBL] [Abstract][Full Text] [Related]
8. [Effects of nizatidine, a new histamine H2-receptor antagonist, on gastric acid secretion and various gastric and duodenal lesions in rats: comparison with cimetidine].
Okabe S; Takeuchi K; Okada M; Kumadaki Y; Nakata M; Nakata H
Nihon Yakurigaku Zasshi; 1989 Mar; 93(3):133-44. PubMed ID: 2567267
[TBL] [Abstract][Full Text] [Related]
9. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
[TBL] [Abstract][Full Text] [Related]
10. Gastric antisecretory and pharmacologic properties of N,N-dimethyl-N'-(2-diisopropylaminoethyl)-N-(4,6-dimethyl-2-pyridyl)ur ea (L-634,366).
Torchiana ML; Cook PG; Hanson CA; Wesley CA; Westrick BL; Wiese SR; Risley EA; Williams M
Arch Int Pharmacodyn Ther; 1986 May; 281(1):120-33. PubMed ID: 2875693
[TBL] [Abstract][Full Text] [Related]
11. A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist.
Brittain RT; Daly MJ
Scand J Gastroenterol Suppl; 1981 Jun; 69():1-9. PubMed ID: 6119770
[TBL] [Abstract][Full Text] [Related]
12. The excitatory effect of the new histamine H2-receptor antagonist nizatidine (LY 139037) on the guinea pig ileum.
Kounenis G; Koutsoviti-Papadopoulou M; Elezoglou V
J Pharmacobiodyn; 1987 Nov; 10(11):669-72. PubMed ID: 2895808
[TBL] [Abstract][Full Text] [Related]
13. Interactions between histaminergic and cholinergic pathways of gastric motility regulation.
Milenov K; Todorov S; Vassileva M; Zamfirova R; Shahbazian A
Methods Find Exp Clin Pharmacol; 1996; 18(1):33-9. PubMed ID: 8721254
[TBL] [Abstract][Full Text] [Related]
14. Topical aspirin plus HCl gastric lesions in the rat. Cytoprotective effect of prostaglandin, cimetidine, and probanthine.
Guth PH; Aures D; Paulsen G
Gastroenterology; 1979 Jan; 76(1):88-93. PubMed ID: 361495
[TBL] [Abstract][Full Text] [Related]
15. Anti-ulcer and secretion-inhibitory properties of the tricyclic derivative doxepin in rats and dogs.
Leitold M; Fleissig W; Merk A
Arzneimittelforschung; 1984; 34(4):468-73. PubMed ID: 6547610
[TBL] [Abstract][Full Text] [Related]
16. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
Griesbacher T; Sametz W; Legat FJ; Diethart S; Hammer S; Juan H
Br J Pharmacol; 1997 Jun; 121(3):469-76. PubMed ID: 9179388
[TBL] [Abstract][Full Text] [Related]
17. Endocrine effects of a new histamine H2-receptor antagonist, nizatidine (LY139037), in the male rat.
Neubauer BL; Goode RL; Best KL; Hirsch KS; Lin TM; Pioch RP; Probst KS; Tinsley FC; Shaar CJ
Toxicol Appl Pharmacol; 1990 Feb; 102(2):219-32. PubMed ID: 1967857
[TBL] [Abstract][Full Text] [Related]
18. Carrier-mediated active transport of histamine H2 receptor antagonists, cimetidine and nizatidine, into isolated rat hepatocytes: contribution of type I system.
Nakamura H; Sano H; Yamazaki M; Sugiyama Y
J Pharmacol Exp Ther; 1994 Jun; 269(3):1220-7. PubMed ID: 7912279
[TBL] [Abstract][Full Text] [Related]
19. Evidence for histamine H1 and H2 receptors in guinea-pig oxyntic cells.
Vinik AI; Heldsinger AA; Skoglund ML
J Pharmacol Exp Ther; 1983 Oct; 227(1):115-21. PubMed ID: 6137553
[TBL] [Abstract][Full Text] [Related]
20. Histamine receptors in the myenteric plexus-longitudinal muscle of the guinea-pig ileum: H1- and H2-receptor-mediated potentiation of the contractile response to electrical stimulation.
Zavecz JH; Yellin TO
J Pharmacol Exp Ther; 1982 Oct; 223(1):177-82. PubMed ID: 6126581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]